Johnson Controls International (NYSE:JCI) Cut to Neutral at Mizuho
Mizuho cut shares of Johnson Controls International (NYSE:JCI – Free Report) from a buy rating to a neutral rating in a report issued on Friday,...
IMAX’s (IMAX) “Outperform” Rating Reiterated at Wedbush
Wedbush reiterated their outperform rating on shares of IMAX (NYSE:IMAX – Free Report) in a research note released on Friday morning, MarketBeat reports. The brokerage...
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Receives Average Rating of “Moderate Buy” from Brokerages
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report) has been given a consensus rating of “Moderate Buy” by the thirteen brokerages that are covering the...
Seres Therapeutics, Inc. (NASDAQ:MCRB) Given Average Recommendation of “Moderate Buy” by Brokerages
Seres Therapeutics, Inc. (NASDAQ:MCRB – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the five analysts that are covering the stock,...
Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives $24.61 Consensus PT from Analysts
Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the ten research firms that...
Quisitive Technology Solutions, Inc. (CVE:QUIS) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Quisitive Technology Solutions, Inc. (CVE:QUIS – Get Free Report) has earned a consensus rating of “Moderate Buy” from the seven ratings firms that are presently...